Extraction of Oligonucleotides From Plasma Samples Across Multiple Species Using OligoWorks™ SPE Microplate Kit

Importance of the Topic

Oligonucleotide therapeutics are emerging as powerful tools for precise modulation of disease pathways through gene transcription and translation control. Their clinical success depends on reliable bioanalytical methods to quantify low-abundance oligonucleotides in complex biological matrices. Sample preparation, particularly overcoming tight oligonucleotide–protein interactions in plasma, is critical to achieve high recovery and sensitivity.

Study Objectives and Overview

This application note evaluates the performance of the OligoWorks SPE Microplate Kit combined with RapiZyme Proteinase K digestion to extract diverse oligonucleotides from plasma across multiple species, including human. The goal is to demonstrate a straightforward workflow delivering consistent recoveries without method adjustments.

Methodology and Instrumentation

• Plasma samples are first subjected to a 1-hour protein digestion at 55 °C using RapiZyme Proteinase K.
• A 1:1 water dilution follows digestion to minimize analyte breakthrough during SPE loading.
• Anion exchange SPE is performed in a 96-well OligoWorks microplate.
• Extracts are analyzed by LC-MS/MS using multiple-reaction monitoring.

Used Instrumentation

• OligoWorks SPE Microplate Kit (p/n 186010614)
• RapiZyme Proteinase K Digestion Module
• ACQUITY UPLC I-Class PLUS System
• Waters Xevo TQ-XS Tandem Quadrupole Mass Spectrometer
• ACQUITY UPLC Premier Oligonucleotide C18 Column, 130 Å, 1.7 µm, 2.1×50 mm (p/n 186009484)

Key Results and Discussion

Using the unmodified protocol, oligonucleotide recoveries ranged from 56 % to 115 % across a panel of test sequences. The 1:1 dilution step effectively reduced SPE breakthrough, ensuring consistent recoveries. Data illustrate the method’s robustness for various chemical modifications and species differences in plasma composition.

Benefits and Practical Applications

• High and reproducible recoveries without method reoptimization
• Simplified sample handling using microplate format
• Compatibility with multiple preclinical species and sample throughput demands
• Enables sensitive LC-MS quantitation of therapeutic oligonucleotides

Future Trends and Potential Applications

Advances may include automation of the SPE workflow, integration with high-resolution MS detection for fragment identification, expansion to other biological matrices, and adaptation to next-generation oligonucleotide chemistries. The platform’s flexibility supports accelerated preclinical and clinical bioanalysis.

Conclusion

The combination of Proteinase K digestion and OligoWorks SPE Microplate delivers a turnkey solution for efficient oligonucleotide extraction from plasma. The protocol yields high recoveries across multiple species, facilitating robust bioanalytical assays for therapeutic development.